Biotraceit

biotraceit corporation has developed paintrace®. the only patented devices and technologies for non-invasive and continuous pain monitoring. the company’s approach uses a wearable medical device to measure pain through the acquisition of direct biosignals that quantify the nervous system’s response to pain. the device provides an instantaneous, real time, numeric readout indicating a level of pain (or the absence of pain). pain measurements can be stored and transmitted wirelessly, allowing healthcare providers to track and analyze a patient’s pain level during exams or over follow-up periods. quantify pain levels can potentially aid healthcare providers to target the most effective treatments and also evaluate patients'​ outcomes to improve pain management and positively impact an individual's return to wellness. pursuant to fda regulations, paintrace® is currently classified as an investigational device used in clinical studies. to conduct or participate in studies please contact us.